Special 10/2012

  • European Biocapital

    Relevant capital market players only!: Will Europe see a return of venture capital in 2012?


    Recent positive signals raise hope. A number of venture capital firms have closed new investment funds, while US-american VCs are attracted by a less crowded capital market on the continent. Industry veterans remain cautious as they wait for the first investments to be announced. In this special, EuroBiotechNews will focus on novelties and trends in the European Biocapital market.

Volume 2014

Volume 2013

Volume 2012

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/magazine/spezial/2012/10/pos/1.html?cHash=8305edff5982cb307c5ea48106acb36a&sort=desc

Current issue

All issues

Events

All Events

Product of the week

Products